Urinary trypsin inhibitor (UTI) forms membrane complexes with UTI-
binding proteins (UTI-BPs) and initiates modulation of
urokinase-type plasminogen activator (uPA) expression, which results in UTI-mediated suppression of cell invasiveness. It has been established that suppression of uPA expression and invasiveness by UTI is mediated through inhibition of
protein kinase C-dependent signaling pathways and that human
chondrosarcoma cell line HCS-2/8 expresses two types of UTI-BPs; a 40-kDa UTI-BP (UTI-BP(40)), which is identical to
link protein (LP), and a 45-kDa UTI-BP (UTI-BP(45)). Here we characterize binding properties of UTI-BPs.UTI complexes in the cells. In vitro
ligand blot, cell binding and competition assays, and Scatchard analyses demonstrate that both
UTI-BP(40) and UTI-BP(45) bind (125)I-UTI. A deglycosylated form of UTI (NG-UTI), from which the
chondroitin-sulfate side chain has been removed, binds only to
UTI-BP(40). Additional experiments, using various
reagents to block binding of (125)I-UTI and NG-UTI to the
UTI-BP(40) and UTI-BP(45) confirm that the
chondroitin sulfate side chain of UTI is required for its binding to UTI-BP(45). Analysis of binding of (125)I-UTI and NG-UTI to the cells suggests that low affinity binding sites are the
UTI-BP(40) (which can bind NG-UTI), and the high affinity sites are the UTI-BP(45). In addition, UTI-induced suppression of
phorbol ester stimulated up-regulation of uPA is inhibited by
reagents that were shown to prevent binding of UTI to the 40- and 45-kDa
proteins. We conclude that UTI must bind to both of the UTI-BPs to suppress uPA up-regulation.